Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

Chromatography companies recognize significant opportunities in the biotech and pharma sectors, yet face uncertainty driven by rising tariffs and the growing integration of AI tools.

To tackle the inequity in medication access, a societal issue especially in developing nations, a team of undergraduate student-researchers at the University of Ottawa has developed a new ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, outlines the ways that tariffs disrupt pharma supply ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

Basically, a brand-name drug company settles a patent infringement lawsuit by paying cash or transferring something else of ...

Ed Kaplan, the national health practice leader at Segal, also has concerns about "any willing provider" strategies.

Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using ...

Another pressing concern for participants was the rise in drug costs, with 54% expecting at least half of U.S. states to establish drug-affordability boards. Additionally, 97% foresee a 25% surge in ...

In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...

The 11th International Granulation Workshop will be held in 2025. The workshop consists of two parts: a 2-day hands-on Course ...

Shares of Viking Therapeutics VKTX gained more than 11% on Wednesday after the company announced that it had signed a broad ...